Literature DB >> 24849898

A role of peripheral myelin protein 2 in lipid homeostasis of myelinating Schwann cells.

Jennifer Zenker1, Mark Stettner, Salla Ruskamo, Enric Domènech-Estévez, Hasna Baloui, Jean-Jacques Médard, Mark H G Verheijen, Jos F Brouwers, Petri Kursula, Bernd C Kieseier, Roman Chrast.   

Abstract

Peripheral myelin protein 2 (Pmp2, P2 or Fabp8), a member of the fatty acid binding protein family, was originally described together with myelin basic protein (Mbp or P1) and myelin protein zero (Mpz or P0) as one of the most abundant myelin proteins in the peripheral nervous system (PNS). Although Pmp2 is predominantly expressed in myelinated Schwann cells, its role in glia is currently unknown. To study its function in PNS biology, we have generated a complete Pmp2 knockout mouse (Pmp2(-/-) ). Comprehensive characterization of Pmp2(-/-) mice revealed a temporary reduction in their motor nerve conduction velocity (MNCV). While this change was not accompanied by any defects in general myelin structure, we detected transitory alterations in the myelin lipid profile of Pmp2(-/-) mice. It was previously proposed that Pmp2 and Mbp have comparable functions in the PNS suggesting that the presence of Mbp can partially mask the Pmp2(-/-) phenotype. Indeed, we found that Mbp lacking Shi(-/-) mice, similar to Pmp2(-/-) animals, have preserved myelin structure and reduced MNCV, but this phenotype was not aggravated in Pmp2(-/-) /Shi(-/-) mutants indicating that Pmp2 and Mbp do not substitute each other's functions in the PNS. These data, together with our observation that Pmp2 binds and transports fatty acids to membranes, uncover a role for Pmp2 in lipid homeostasis of myelinating Schwann cells.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  Pmp2; fatty acid transport; glia; myelin basic protein; peripheral nervous system

Mesh:

Substances:

Year:  2014        PMID: 24849898     DOI: 10.1002/glia.22696

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  31 in total

1.  Production, crystallization and neutron diffraction of fully deuterated human myelin peripheral membrane protein P2.

Authors:  Saara Laulumaa; Matthew P Blakeley; Arne Raasakka; Martine Moulin; Michael Härtlein; Petri Kursula
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-10-23       Impact factor: 1.056

2.  Neuregulin 1 type III improves peripheral nerve myelination in a mouse model of congenital hypomyelinating neuropathy.

Authors:  Sophie Belin; Francesca Ornaghi; Ghjuvan'Ghjacumu Shackleford; Jie Wang; Cristina Scapin; Camila Lopez-Anido; Nicholas Silvestri; Neil Robertson; Courtney Williamson; Akihiro Ishii; Carla Taveggia; John Svaren; Rashmi Bansal; Markus H Schwab; Klaus Nave; Pietro Fratta; Maurizio D'Antonio; Yannick Poitelon; M Laura Feltri; Lawrence Wrabetz
Journal:  Hum Mol Genet       Date:  2019-04-15       Impact factor: 6.150

3.  The Role of Peripheral Myelin Protein 2 in Remyelination.

Authors:  Mark Stettner; Jennifer Zenker; Fabian Klingler; Fabian Szepanowski; Hans-P Hartung; Anne K Mausberg; Christoph Kleinschnitz; Roman Chrast; Bernd C Kieseier
Journal:  Cell Mol Neurobiol       Date:  2017-04-26       Impact factor: 5.046

4.  Cryo-EM, X-ray diffraction, and atomistic simulations reveal determinants for the formation of a supramolecular myelin-like proteolipid lattice.

Authors:  Salla Ruskamo; Oda C Krokengen; Julia Kowal; Tuomo Nieminen; Mari Lehtimäki; Arne Raasakka; Venkata P Dandey; Ilpo Vattulainen; Henning Stahlberg; Petri Kursula
Journal:  J Biol Chem       Date:  2020-04-07       Impact factor: 5.157

5.  Involvement of Nuclear Receptor REV-ERBβ in Formation of Neurites and Proliferation of Cultured Adult Neural Stem Cells.

Authors:  Koji Shimozaki
Journal:  Cell Mol Neurobiol       Date:  2018-02-03       Impact factor: 5.046

6.  Enhanced axonal neuregulin-1 type-III signaling ameliorates neurophysiology and hypomyelination in a Charcot-Marie-Tooth type 1B mouse model.

Authors:  Cristina Scapin; Cinzia Ferri; Emanuela Pettinato; Desiree Zambroni; Francesca Bianchi; Ubaldo Del Carro; Sophie Belin; Donatella Caruso; Nico Mitro; Marta Pellegatta; Carla Taveggia; Markus H Schwab; Klaus-Armin Nave; M Laura Feltri; Lawrence Wrabetz; Maurizio D'Antonio
Journal:  Hum Mol Genet       Date:  2019-03-15       Impact factor: 6.150

7.  Exome Sequence Analysis Suggests that Genetic Burden Contributes to Phenotypic Variability and Complex Neuropathy.

Authors:  Claudia Gonzaga-Jauregui; Tamar Harel; Tomasz Gambin; Maria Kousi; Laurie B Griffin; Ludmila Francescatto; Burcak Ozes; Ender Karaca; Shalini N Jhangiani; Matthew N Bainbridge; Kim S Lawson; Davut Pehlivan; Yuji Okamoto; Marjorie Withers; Pedro Mancias; Anne Slavotinek; Pamela J Reitnauer; Meryem T Goksungur; Michael Shy; Thomas O Crawford; Michel Koenig; Jason Willer; Brittany N Flores; Igor Pediaditrakis; Onder Us; Wojciech Wiszniewski; Yesim Parman; Anthony Antonellis; Donna M Muzny; Nicholas Katsanis; Esra Battaloglu; Eric Boerwinkle; Richard A Gibbs; James R Lupski
Journal:  Cell Rep       Date:  2015-08-06       Impact factor: 9.423

8.  Gender-specific differences in diabetic neuropathy in BTBR ob/ob mice.

Authors:  Phillipe D O'Brien; Junguk Hur; Nicholas J Robell; John M Hayes; Stacey A Sakowski; Eva L Feldman
Journal:  J Diabetes Complications       Date:  2015-10-03       Impact factor: 2.852

9.  De novo PMP2 mutations in families with type 1 Charcot-Marie-Tooth disease.

Authors:  William W Motley; Paulius Palaima; Sabrina W Yum; Michael A Gonzalez; Feifei Tao; Julia V Wanschitz; Alleene V Strickland; Wolfgang N Löscher; Els De Vriendt; Stefan Koppi; Livija Medne; Andreas R Janecke; Albena Jordanova; Stephan Zuchner; Steven S Scherer
Journal:  Brain       Date:  2016-03-23       Impact factor: 13.501

10.  Identification of a pathogenic PMP2 variant in a multi-generational family with CMT type 1: Clinical gene panels versus genome-wide approaches to molecular diagnosis.

Authors:  Jaya Punetha; Loren Mackay-Loder; Tamar Harel; Zeynep Coban-Akdemir; Shalini N Jhangiani; Richard A Gibbs; Ian Lee; Deborah Terespolsky; James R Lupski; Jennifer E Posey
Journal:  Mol Genet Metab       Date:  2018-08-24       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.